The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical ...
Agence France-Presse on MSN
US medical agency will scale back testing on monkeys
The United States will scale back certain drug-safety testing requirements on monkeys, federal regulators said Tuesday, ...
Clinical Trials Arena on MSN
FDA steps back from preclinical primate testing amid wider regulatory shift
New non-primate draft guidance follows the agency’s wider aim to curtail the use of animal testing in preclinical toxicology.
FDA decision aligns with Trump administration’s effort to lower pharma costs by eliminating lab monkey requirement ...
The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...
The draft guidance issued Tuesday comes as regulators and policymakers have looked for ways to aid U.S. drugmakers amid fast progress by their China-based counterparts.
On , The US Food and Drug Administration issued draft guidance identifying specific types of monoclonal antibody products for which the agency believes six-month toxicity testing in non-human primates ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
Researchers have created functional brain-like tissue without relying on any animal-derived materials, marking a major step toward more ethical and reproducible neurological research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback